CASE-138 · Engineering case

Fermentation Extract Manufacturing Commercialization

Qualified commercial manufacturing train with controlled formulation, repeatable product quality, trained operators, and released batch documentation.

Why the Work Mattered

Purpose and Operating Need

Selected Stage-gate with pilot and scale-up loops at High / deliberate effort and Standard speed; sequenced as Wave 2.

Engineering Approach

Delivered process scope included extraction, screening and separation, centrifugation, microfiltration, ion exchange, sodium-hydroxide pH adjustment, evaporation, refrigerated hold, thermal treatment, drying, grinding, standardization, final screening, metal detection, vacuum packaging, QC release, utilities, controls, and operating readiness. GRN 884 identifies pasteurization as CCP1 and final screening as CCP2, with a 1.5% maximum intended-use basis and 5-7% naturally occurring phosphates. Led specification, procurement, construction, integration, commissioning, qualification and turnover of the commercial RBE manufacturing train and its utilities, controls, sanitation, and release interfaces.

Outcome & Engineering Context

Outcome and Context

Delivered RBE process train through accepted operational turnover and closeout.

Measures & Operating Detail

Measure	Value	Type & meaning	Attribution & operating context
Forecast Variance to Budget	256,000 USD	Scenario or Model Result Forecast variance	Applies to: Fermentation Extract Manufacturing Commercialization Portfolio project register — Budget less estimate at completion; distinct from the difference between budget and final actual cost.
Process Steps	9 steps	Scope or Inventory Quantity Recorded process architecture	Applies to: Fermentation Extract Manufacturing Commercialization RBE manufacturing train — Nine process steps are recorded in the project capability result.
Maximum Intended Use	<= 1.5 %	Design Parameter Product-use specification	Applies to: Fermentation Extract Manufacturing Commercialization GRN 884 basis — Maximum intended-use basis for the rice-bran extract; not a process yield.
Naturally Occurring Phosphate Content	5 to 7 %	Design Parameter Product composition context	Applies to: Fermentation Extract Manufacturing Commercialization GRN 884 basis — Naturally occurring phosphates in the recorded product basis.

Engineering scope and design basis

Food ingredients manufacturer Capital Project Engineer; owning workstream PG-B-01; authority VP Manufacturing.

2012-03-01 to 2014-07-30; budget $12,800,000; forecast variance (budget less EAC) $256,000.

Directed the translation of approved scope into procurement and supplier-data requirements, construction/configuration work packages, inspection and change records, mechanical completion and readiness evidence.

Used requirements-to-acceptance traceability, WBS and control schedule, cost/resource registers, agreements and acceptance records, baselines, risk/change controls, commissioning evidence, training, and G9 ownership transfer.

Raw/intermediate/treated/dry-finished zoning; post-lethality protection; controlled regeneration and pH-reagent addition; cold-hold limits; thermal qualification; cleaning and pre-operation release; hygienic dryer discharge; packaging sanitation; quarantine; analytical and microbiological release.

76 controlled project documents across nine lifecycle phases, 362 linked execution records, accepted G1-G9 gates, and final baseline PRJ-B-001-BL-OT-B01.

OPERATIONAL / CLOSED; 9 process steps; GRN 884 basis; 1.5% maximum intended-use basis; operational turnover completed

Operations received RBE process train with accepted configuration, procedures, training, asset and maintenance records, residual-item disposition, and ownership.

Delivered RBE process train, measured by 9 process steps; GRN 884 basis; 1.5% maximum intended-use basis; operational turnover completed, by executing Stage-gate with pilot and scale-up loops from concept through G9 closeout.

Actions, Methods & Controls

ACTIVITIES IN CONTEXT